Endolipid Therapeutics Revenue

Biotechnology Research • Barcelona, Catalonia, Spain • 1-10 Employees

Endolipid Therapeutics revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding

Key Contact at Endolipid Therapeutics

Giacomo De Simone

Chief Executive Officer

Company overview

Headquarters	Passeig de la Vall d’Hebron 119-129, Barcelona , Spain, Barcelona, Barcelona 08035, ES
Website	endolipid.com
NAICS	541714
Founded	2021
Employees	1-10
Socials

About Endolipid Therapeutics

Mimicking the action of Sex Hormone Binding Globulin (SHBG) effectively reduces ectopic fat, fibrosis and inflammation. Endolipid Tx is developing two novel peptides with validated efficacy - in vivo PoC: EDL6D for NASH and EDL3D for Cellulite/Slimming. NASH is a growing and underserved disease. Endolipid Tx is developing EDL6D, an in vivo effective peptide that may offer a treatment opportunity for NASH with a novel and differentiated mechanism of action. Cellulite and Slimming are poorly attended pathologies with scarce therapeutic innovation in the last 10 years. Endolipid Tx is developing EDL81, a peptide with a innovative mode of action and proven in vitro and in vivo efficacy in reducing ectopic fat in Cellulite and Slimming.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Endolipid Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Endolipid Therapeutics has never raised funding before.

Endolipid Therapeutics Tech Stack

Discover the technologies and tools that power Endolipid Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Smart Slider 3

WordPress plugins

Google Maps

Maps

jQuery Migrate

JavaScript libraries

Genesis theme

WordPress themes

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Gutenberg

Editors

Google Analytics

Analytics

Moment.js

JavaScript libraries

RankMath SEO

SEO

Google Tag Manager

Tag managers

Frequently asked questions

Endolipid Therapeutics is located in Barcelona, Catalonia, ES.

Endolipid Therapeutics generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

Endolipid Therapeutics has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Endolipid Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Endolipid Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Endolipid Therapeutics

Giacomo De Simone

Chief Executive Officer

4.8

40,000 users